Cancer cells subvert fibroblast function to promote a growth factor enriched tumor microenvironment in endocrine therapy resistant ER plus breast cancer

被引：0
作者：
Griffiths, Jason I.
Cosgrove, Patrick A.
Castaneda, Eric Medina
Nath, Aritro
Chen, Jinfeng
Adler, Frederick R.
Chang, Jeffrey T.
Khan, Qamar J.
Bild, Andrea H.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5693
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5693
引用
收藏
页数：2
相关论文
共 50 条
[41]   BREAST CANCER PATIENTS RESISTANT TO ENDOCRINE THERAPY ARE IMMUNODEFICIENT AND SHOW ENHANCED TRANSFORMING GROWTH FACTOR - BETA AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN PLASMA [J].
Zavadova, E. ;
Konopasek, B. ;
Vocka, M. ;
Fucikova, T. ;
Petruzelka, L. .
ANNALS OF ONCOLOGY, 2012, 23 :81-81
[42]   Mutation signature of patients with ER plus metastatic breast cancer who received endocrine therapy. [J].
Ma, Fei ;
Zhang, Yan ;
Ouyang, Quchang ;
Dai, Pingping ;
Yi, Zongbi ;
Cao, Weiguo ;
Zhou, Yidong ;
Zhu, Chenchen ;
Guan, Yan-Fang ;
Yang, Ling ;
Yi, Xin ;
Xia, Xuefeng .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[43]   Semaphorin 7a promotes cell survival and resistance to endocrine therapy in ER plus breast cancer [J].
Lyons, Traci Renae .
CANCER RESEARCH, 2020, 80 (16)
[44]   Growth factor stimulation induces a distinct ERα cistrome underlying breast cancer endocrine resistance [J].
Lupien, Mathieu ;
Meyer, Clifford A. ;
Bailey, Shannon T. ;
Eeckhoute, Jerome ;
Cook, Jennifer ;
Westerling, Thomas ;
Zhang, Xiaoyang ;
Carroll, Jason S. ;
Rhodes, Daniel R. ;
Liu, X. Shirley ;
Brown, Myles .
GENES & DEVELOPMENT, 2010, 24 (19) :2219-2227
[45]   The impact of endocrine fibroblast growth factor subfamily as serum biomarkers in castration-resistant prostate cancer [J].
Teishima, Jun ;
Yamaguchi, Yuka ;
Nagamatsu, Hirotaka ;
Fujii, Shinsuke ;
Yabumoto, Naoya ;
Goto, Keisuke ;
Shinmei, Shunsuke ;
Inoue, Shogo ;
Hayashi, Tetsutaro ;
Matsubara, Akio .
CANCER SCIENCE, 2018, 109 :1078-1078
[46]   Significance of endocrine fibroblast growth factor subfamily as serum biomarkers in castration-resistant prostate cancer [J].
Teishima, Jun ;
Yamaguchi, Yuka ;
Nagamatsu, Hirotaka ;
Shikuma, Hiroyuki ;
Fujii, Shinsuke ;
Goto, Keisuke ;
Shinmei, Shunsuke ;
Inoue, Shogo ;
Hayashi, Tetsutaro ;
Matsubara, Akio .
CANCER SCIENCE, 2018, 109 :996-996
[47]   Estrogen Receptor Alpha Negative (ER-) Breast Cancer Stem Cells in ER plus Cell Lines and Primary Cancers Are Enriched by Tamoxifen Therapy [J].
O'Brien, C. S. ;
Howell, S. J. ;
Gandhi, A. ;
Gee, J. ;
Lykkesfeldt, A. ;
Nicholson, R. I. ;
Clarke, R. B. .
CANCER RESEARCH, 2010, 70
[48]   The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer [J].
Rodriguez, David ;
Ramkairsingh, Marc ;
Lin, Xiaozeng ;
Kapoor, Anil ;
Major, Pierre ;
Tang, Damu .
CANCERS, 2019, 11 (07)
[49]   Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer [J].
Bahnassy, Shaymaa ;
Stires, Hillary ;
Jin, Lu ;
Tam, Stanley ;
Mobin, Dua ;
Balachandran, Manasi ;
Podar, Mircea ;
Mccoy, Matthew D. ;
Beckman, Robert A. ;
Riggins, Rebecca B. .
ENDOCRINOLOGY, 2023, 164 (12) :1-15
[50]   A circRNA-mRNA pairing mechanism regulates tumor growth and endocrine therapy resistance in ER- positive breast cancer [J].
Yi, Jia ;
Du, Jiao ;
Chen, Xue ;
Nie, Rui-chao ;
Hu, Guo-sheng ;
Wang, Lei ;
Zhang, Yue-ying ;
Chen, Shang ;
Wen, Xiao-sha ;
Luo, Di-xian ;
He, Hua ;
Liu, Wen .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2025, 122 (08)
12345